Medicare GLP-1 Bridge: Your Step-by-Step July 1 Guide
Author
glp winnerDate Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
Starting July 1, 2026, eligible Medicare Part D members can get certain GLP-1 weight-loss medications for a flat $50 a month payment through a new program called the Medicare GLP-1 Bridge. This walkthrough explains what the Bridge is, who qualifies, which drugs are covered, and exactly how the first month works, including one timing detail that has tripped people up.
Who This Helps
This is for people with Medicare Part D coverage who want help paying for a GLP-1 weight-loss medication, and for the family members helping them sort it out. It is also useful if you have already been on a GLP-1 and want to know whether you can move onto the Bridge.
Does the Bridge Change Your Current Coverage?
The Bridge does not take anything away from you. It is a new, separate way to get certain weight-loss GLP-1s for $50 a month, running alongside your regular Part D coverage rather than replacing it. If you take a GLP-1 for an approved health reason that is covered by your Medicare plan today, that stays under your normal Part D benefit, and the Bridge is an added option for weight management (CMS).
What the Bridge Is and How Long It Lasts
The Medicare GLP-1 Bridge is a short-term demonstration from CMS that gives eligible Part D members access to certain GLP-1 weight-loss drugs from July 1, 2026 through December 31, 2027. CMS originally planned for it to end in December 2026 and then extended it through the end of 2027 while it gathers data (KFF).
What You Will Pay
You pay a flat $50 for each 30-day supply, and that amount stays the same no matter which covered drug or dose you are on. The $50 does not count toward your Part D deductible, and it does not count toward your annual out-of-pocket maximum (CMS). That out-of-pocket maximum is $2,100 in 2026 and $2,400 in 2027, and your Bridge copays sit outside it, staying at $50 a month regardless of where you are in your Part D benefit for the year (KFF).
Which Drugs Are Covered
The Bridge covers three weight-loss medications when used to reduce excess body weight: Foundayo, which is taken by mouth; Wegovy in both its injection and tablet forms (Wegovy Pill); and Zepbound in the KwikPen form only (CMS). Wegovy is an FDA-approved medicine that contains semaglutide, a GLP-1 receptor agonist, and Zepbound is an FDA-approved medicine that contains tirzepatide, a dual GIP and GLP-1 receptor agonist.
A few things are not on the Bridge list. The single-dose vial and single-dose pen versions of Zepbound are not covered, only the KwikPen is (this was clarified in April 2026). Ozempic and Mounjaro are not on the covered list for the Bridge, though they may still be covered under regular Part D when used for type 2 diabetes. Only the specific brand-name products on the list qualify, so other products, including compounded GLP-1 versions, fall outside it.
Do You Qualify?
To use the Bridge, you must be enrolled in a Medicare Part D plan and be at least 18, and meet one of three weight-and-health combinations. The exact criteria are:
- a body mass index of 35 or higher on its own;
- a BMI of 30 or higher along with heart failure with preserved ejection fraction, uncontrolled high blood pressure above 140/90 while on two blood pressure medications, or chronic kidney disease at stage 3a or above;
- a BMI of 27 or higher along with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease
(CMS Information for Providers).
Your eligibility numbers are measured at the time you first started GLP-1 therapy, not the day your paperwork is filed. So if your BMI was 37 when you started and has since come down, you can still qualify under that starting number. That helps people who have already lost weight on a GLP-1 and worry they no longer make the cutoff.
How the First Month Actually Works
Nothing in the Bridge process can begin before July 1, 2026. You can see your provider and get ready before then, but no prior authorization can be filed early, because the program does not start accepting anything until that date (CMS Information for Providers).
Once the program opens, approval follows a two-step order rather than a single form. First your provider sends the prescription to a pharmacy. The pharmacy then sends back a request to complete a prior authorization. Your provider submits that prior authorization, and the prescription has to be marked as being for weight management or the request can stall before it gets to that step (CMS Information for Providers).
The approval does not go to your own Part D plan. CMS routes all of it through a single central processor, Humana, which already runs a Medicare program called LI NET, and that processor handles the prior authorization, the claim, and the payment to the pharmacy (CMS Information for Pharmacies). Your pharmacy does not need to sign up in advance, and once you are approved, you pay your $50 at the counter and pick up your medication.
What this means for you: the most useful thing you can do before July is book a visit with a provider so your prescription is ready to send the moment the window opens. The paperwork itself happens after July 1, but being seen and ready ahead of time means you are not starting from scratch that week.
Who Can Write Your Prescription
You do not need a special Medicare-enrolled doctor for this. A provider does not have to be enrolled in Medicare to write the prescription or submit the prior authorization under the Bridge. The only bar is that the provider must not be on the CMS Preclusion List, which is a list of providers blocked from being paid for Medicare drugs and services (CMS Preclusion List). That means your primary care doctor, a nurse practitioner, a physician assistant, an obesity or kidney specialist, or a telehealth clinician who sees Medicare patients can all handle it. For questions about your own coverage and timing, your Part D plan is the right place to ask.
Final Takeaway
The Medicare GLP-1 Bridge gives eligible Part D members a real, lower-cost path to certain weight-loss medications for $50 a month. The program runs from July 2026 through the end of 2027, so there is time to do this right. The biggest thing to remember is that nothing can be filed before July 1, so the smart move is to get seen and ready beforehand. Any provider not on the Preclusion List can submit the prior authorization once the window opens. Keep your starting weight numbers in mind, since those are what count for eligibility. And for coverage questions specific to you, go to your Part D plan. This is a steady, well-defined process, and knowing the order of the steps gets you most of the way there.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Sources
Keep Reading
Medicaid coverage for GLP-1s expands through December 2031 under the BALANCE Model. Eligibility, pricing, and what to ask your state Medicaid agency.
Starting July 1, 2026, Medicare Part D patients could get GLP-1s for $50/month. Here's who qualifies, what's covered, and what's still in motion.
Medicare covers Wegovy and Zepbound for $50/month starting July 2026. Learn who qualifies, what it costs, and how to prepare for the GLP-1 Bridge.
Curated by
